Popovic et al. used an antagonist for the IL-1 receptor, anakinra, administered in 17 patients with PCOS; the patients were given 100 mg of anakinra daily for 28 days [30] after which CRP and **androgen levels were measured [34]. This evidence concerns the gene CRP and polycystic ovary syndrome.